SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation and anticipation of potential cannabis rescheduling following comments from President Trump, which could ease tax burdens and banking restrictions for cannabis companies. The community is discussing potential short squeezes and the impact on both US and Canadian cannabis companies, with some investors highlighting Tilray's existing European presence while others favor US-focused operators. Overall, excitement and caution are both present as traders await further developments and assess potential market impacts.

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.

Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc. (PCSA) is trending due to positive preliminary Phase 2 data for its metastatic breast cancer treatment, PCS6422, showing increased efficacy without additional toxicity. This development, coupled with a recent reverse stock split creating a significantly lower share float, has fueled intense community discussion and speculation about parabolic potential and a notable short squeeze.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as it pursues a lawsuit against two investment firms for alleged stock price manipulation to trigger Contingent Value Rights, a move that has ignited debate among investors about the company's valuation. This legal action, alongside a new "Overweight" rating and $31 price target from Cantor Fitzgerald, contrasts with community frustration over persistent price declines and calls for clearer communication on buybacks and cash flow despite its substantial contracts in the AI sector.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is currently trending with strong upward momentum, fueled by escalating industrial demand from AI, EV, and solar technologies, alongside growing concerns over fiat currency debasement. The community is actively discussing a tightening physical silver market due to structural shortages and recent export restrictions from China, leading to widespread anticipation of continued price appreciation despite historical manipulation attempts.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF ($MSOS) is trending as the cannabis sector anticipates a potential executive order to reclassify marijuana to Schedule III, a move expected to significantly benefit US-based cannabis companies. This anticipated federal policy shift is generating widespread community optimism, with discussions focusing on the removal of the 280E tax burden and the opening of doors for institutional investment, potentially leading to substantial industry growth.

Hut 8 Corp. operates as a Bitcoin miner that focuses on mining. It provides digital asset mining, hosting, and managed infrastructure operation services. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 Corp is trending significantly following its new AI infrastructure partnership with Anthropic and Fluidstack, featuring a major data center lease agreement notably backed by Google. The community views this strategic pivot from primarily Bitcoin mining towards a diversified AI infrastructure model as a key driver, positioning the company as a prominent provider of essential power capacity for high-performance computing. This diversification aims to enhance valuation and solidify its role in the booming AI sector.

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

Medline Inc - Ordinary Shares - Class A

Medline Inc.

Medline (MDLN) is actively trending following its highly anticipated initial public offering, which has sparked widespread community discussion surrounding allocation sizes and initial price performance. Investors are debating whether this major market debut, backed by a strong position in the medical supplies sector, represents a long-term hold or a quick flip, with some noting its significant debt load as a factor to consider.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending ahead of its highly anticipated earnings report, with analysts raising price targets due to surging demand for AI memory and rising DRAM prices. While many anticipate a blowout report driven by the ongoing memory shortage, some investors are cautious, fearing a "sell the news" reaction or a post-earnings drop similar to other recent semiconductor earnings. This creates a divided community sentiment amidst discussions of a memory supercycle and market volatility.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle's stock is trending due to concerns about its data center financing and debt, particularly after reports of a pulled investment. The community is debating the validity of these concerns, with some seeing a buying opportunity amidst the FUD, while others fear an AI bubble burst and a continued downward trend. Discussions include potential government intervention and comparisons to other tech companies.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock approaches all-time highs, with community members debating whether it will break through the $500 mark soon. Some traders are pointing to potential overvaluation and upcoming negative catalysts, while others cite strong technicals and future growth prospects in autonomy and AI as reasons for continued bullishness. Discussions also include the impact of potential regulatory challenges and the implications of Elon Musk's leadership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Galectin Therapeutics (NASDAQ:GALT) Director Sells $105,273.30 in Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) Director Harold Shlevin sold 16,790 shares of the company's stock in a transaction on Tuesday, December 9th. The shares were sold at an...

Galectin Therapeutics (NASDAQ:GALT) Director Sells $950,820.00 in Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) Director Harold Shlevin sold 159,000 shares of the company's stock in a transaction on Monday, December 8th. The shares were sold at an...

Fund L.P. 10X Sells 120,000 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) major shareholder Fund L.P. 10X sold 120,000 shares of Galectin Therapeutics stock in a transaction on Wednesday, December 3rd. The shares...

Galectin Therapeutics (NASDAQ:GALT) Major Shareholder Fund L.P. 10X Sells 30,000 Shares

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) major shareholder Fund L.P. 10X sold 30,000 shares of the business's stock in a transaction that occurred on Tuesday, December 2nd. The...

Galectin Therapeutics (NASDAQ:GALT) Major Shareholder Sells $164,100.00 in Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) major shareholder Fund L.P. 10X sold 30,000 shares of the firm's stock in a transaction on Tuesday, December 2nd. The shares were sold at an...

Wealthspire Advisors LLC Buys 81,144 Shares of Galectin Therapeutics Inc. $GALT

Wealthspire Advisors LLC lifted its stake in shares of Galectin Therapeutics Inc. (NASDAQ:GALT - Free Report) by 20.4% during the second quarter, according to its most recent filing with the...

Galectin Therapeutics (NASDAQ:GALT) Insider Sells 121,117 Shares

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 121,117 shares of the firm's stock in a transaction dated Thursday, November 13th. The shares were sold at an...

Galectin Therapeutics (NASDAQ:GALT) Releases Earnings Results, Misses Estimates By $0.02 EPS

Galectin Therapeutics (NASDAQ:GALT - Get Free Report) announced its earnings results on Friday. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of...

Khurram Jamil Sells 121,117 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 121,117 shares of the business's stock in a transaction on Thursday, November 13th. The shares were sold at an...

Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened

Galectin Therapeutics (NASDAQ:GALT) Share Price Crosses Above Two Hundred Day Moving Average - What's Next...

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Current Price	$6.98
Prev Close	$6.20
Open	$6.57
Dividend Yield	0.00%
50-Day Moving Average	$5.49
Beta	0.65
Avg. Volume	372,195.11
PE Ratio	-10.49

52-Week High	$6.78
52-Week Low	$0.726
Market Capitalization	$399.77M
EPS (Annual)	-$0.7575
Price to Book	-3.18
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

GALT
Galectin Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GALT News

GALTGalectin Therapeutics Inc